Drug Class
tyrosine kinase inhibitor
Type
ingredient
Active Ingredient
bosutinib
📋Overview
Bosutinib is a medication classified as a tyrosine kinase inhibitor. It is primarily associated with the management of certain types of leukemia, particularly chronic myelogenous leukemia (CML). The drug works by interfering with specific proteins that promote the growth of cancer cells. Bosutinib is typically used in cases where other treatments may not be effective or suitable.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Bosutinib
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.